Patients outcome after treatment of an ovarian cancer by intraperitoneal immunochemotherapy;Devenir des patientes traitees pour un cancer de l'ovaire par immunochimiotherapie intra-peritoneale

Contraception Fertilite Sexualite

Volumn 26, Issue 11, 1998, Pages 790-799

  Zylberberg, B ^a   Dormont, D ^a   Zylberberg, S ^a   Salat Baroux, J ^a   Madelenat, P ^a   Ravina, J H ^a   Zan, S ^a   Darai, E ^a   Antoine, J M ^a   Panel, F ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Encapsulating peritonitis; Immunotherapy; Intraperitoneal and intravenous chemotherapy; Long term complications; Ovarian cancer; Relapses; Secondary cancers; Sodium thiosulfate

Indexed keywords

CISPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT; IMMUNOLOGICAL ADJUVANT;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; MAJOR CLINICAL STUDY; NEPHROTOXICITY; OVARY CANCER; PERITONEUM ADHESION; TREATMENT OUTCOME; ADULT; AGED; FEMALE; HYSTERECTOMY; IMMUNOLOGY; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; OVARY TUMOR; PATHOLOGY; REOPERATION; SURVIVAL; VIBRIO CHOLERAE;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYSTERECTOMY; INJECTIONS, INTRAPERITONEAL; MIDDLE AGED; OVARIAN NEOPLASMS; REOPERATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIBRIO CHOLERAE;

EID: 0032201192     PISSN: 11651083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)